中医临床研究
中醫臨床研究
중의림상연구
CLINICAL JOURNAL OF CHINESE MEDICINE
2014年
27期
55-57
,共3页
2型糖尿病%糖尿病周围神经病变%前列地尔%α-硫辛酸%甲钴胺
2型糖尿病%糖尿病週圍神經病變%前列地爾%α-硫辛痠%甲鈷胺
2형당뇨병%당뇨병주위신경병변%전렬지이%α-류신산%갑고알
Type 2 diabetes%Diabetic peripheral neuropathy%Alprostadil%Alpha lipoic acid and Mecobalamin
目的:观察前列地尔联合α-硫辛酸、甲钴胺治疗2型糖尿病周围神经病变的临床疗效。方法:选择符合入选标准的2型糖尿病周围神经病变患者50例,除了给予常规药物控制血糖,均静脉滴注前列地尔10ug ,1次/天,α-硫辛酸600mg,1次/天,并静脉推注甲钴胺1mg,1次/天。连续用药2周。治疗前后分别记录TCSS评分,正中神经(MN)、腓总神经(CPN)的运动神经传导速度(MNCV)与感觉神经传导速度(SNCV)。结果:治疗后TCSS评分较治疗前显著降低(P<0.05);治疗后MNCV、SNCV与治疗前比较,差异具有统计学意义(P<0.05)。结论:前列地尔联合α-硫辛酸、甲钴胺对2型糖尿病周围神经病变疗效显著。
目的:觀察前列地爾聯閤α-硫辛痠、甲鈷胺治療2型糖尿病週圍神經病變的臨床療效。方法:選擇符閤入選標準的2型糖尿病週圍神經病變患者50例,除瞭給予常規藥物控製血糖,均靜脈滴註前列地爾10ug ,1次/天,α-硫辛痠600mg,1次/天,併靜脈推註甲鈷胺1mg,1次/天。連續用藥2週。治療前後分彆記錄TCSS評分,正中神經(MN)、腓總神經(CPN)的運動神經傳導速度(MNCV)與感覺神經傳導速度(SNCV)。結果:治療後TCSS評分較治療前顯著降低(P<0.05);治療後MNCV、SNCV與治療前比較,差異具有統計學意義(P<0.05)。結論:前列地爾聯閤α-硫辛痠、甲鈷胺對2型糖尿病週圍神經病變療效顯著。
목적:관찰전렬지이연합α-류신산、갑고알치료2형당뇨병주위신경병변적림상료효。방법:선택부합입선표준적2형당뇨병주위신경병변환자50례,제료급여상규약물공제혈당,균정맥적주전렬지이10ug ,1차/천,α-류신산600mg,1차/천,병정맥추주갑고알1mg,1차/천。련속용약2주。치료전후분별기록TCSS평분,정중신경(MN)、비총신경(CPN)적운동신경전도속도(MNCV)여감각신경전도속도(SNCV)。결과:치료후TCSS평분교치료전현저강저(P<0.05);치료후MNCV、SNCV여치료전비교,차이구유통계학의의(P<0.05)。결론:전렬지이연합α-류신산、갑고알대2형당뇨병주위신경병변료효현저。
Objective: To observe the clinical curative effect of alprostadil combined with alpha lipoic acid and Mecobalamin on treating type 2 diabetic peripheral neuropathy. Methods: 50 patients with type 2 diabetic peripheral neuropathy were included. Besides routine drugs to control blood sugar, they all were treated with intravenous infusion of alprostadil 10ug, 1 times/day, alpha lipoic acid 600mg, 1 times/day, and intravenous injection of mecobalamin 1mg, 1 times/day;all medication were kept for two weeks consecutively. TCSS scores were recorded before and after treatment of the median nerve(MN), common peroneal nerve (CPN) in motor nerve conduction velocity (MNCV) and sensory nerve conduction velocity (SNCV). Results: after treatment, TCSS scores decreased significantly (P<0.05);comparing the TCSS scores of MNCV and SNCV before and after the treatment, the difference was statistically significant (P<0.05). Conclusion: alprostadil combined with alpha lipoic acid and methylcobalamin has significant therapeutic effect on peripheral neuropathy in type 2 diabetic mellitus.